Emmune Inc.
Cambridge, MA Doing business as Emmune Inc.
- UEI
- N65ZDYUGWAH8
- CAGE
- 7A4Z5
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 620 Memorial Dr w 100, Cambridge, MA 02139, USA
- Website
- emmune.bio
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Emmune Inc.
Emmune Inc. is a for-profit corporate entity registered in SAM.gov, located in Cambridge, Massachusetts, with a focused research and development approach in biotechnology and therapeutic protein engineering. The company specializes in developing advanced therapeutic solutions for challenging medical conditions, particularly targeting HIV and viral infections through innovative molecular and genetic approaches. Their core expertise appears to center on designing novel protein-based therapeutics, with a particular emphasis on developing long-acting injectable treatments and gene therapy platforms.
Emmune Inc. has secured multiple federal grants from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Center for Advancing Translational Sciences, focusing on cutting-edge research in HIV treatment and vaccine development. Their grant-funded projects include developing non-viral gene therapy platforms with ECD4-IG, a unique antibody-like therapeutic designed to neutralize HIV across diverse viral variants, process development for manufacturing ECD4-IG, and engineering adeno-associated virus (AAV) capsids for enhanced skeletal muscle gene transduction. The company has also engaged in collaborative sub-award work with prestigious research institutions like Fred Hutchinson Cancer Center and Scripps Research Institute, involving characterization of antibody effector functions, developing protein variants, and conducting pre-clinical studies in non-human primates. Their research demonstrates a sophisticated approach to addressing complex medical challenges through advanced protein engineering, immunology, and gene therapy technologies.
Quick answers
What is Emmune Inc.'s UEI?
Emmune Inc.'s Unique Entity ID (UEI) in SAM.gov is N65ZDYUGWAH8.
What is Emmune Inc.'s CAGE code?
Emmune Inc.'s CAGE code is 7A4Z5.
Where is Emmune Inc. located?
Emmune Inc.'s physical address in SAM.gov is 620 Memorial Dr w 100, Cambridge, MA 02139, USA.
Is Emmune Inc. registered in SAM.gov?
Yes. Emmune Inc.'s SAM.gov registration is active through May 11, 2027.
What is Emmune Inc.'s most recent federal award?
Emmune Inc.'s most recent federal grant award is Non-viral gene therapy to treat and prevent atherosclerosis - abstract adeno-associated virus (AAV) vectors can… (R44HL184837), from National Heart Lung and Blood Institute, on September 1, 2026.
On GovTribe
See Emmune Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors